These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 31432449

  • 1. Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.
    Niewiadomska-Cimicka A, Trottier Y.
    Neurotherapeutics; 2019 Oct; 16(4):1074-1096. PubMed ID: 31432449
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. SUMOylation by SUMO2 is implicated in the degradation of misfolded ataxin-7 via RNF4 in SCA7 models.
    Marinello M, Werner A, Giannone M, Tahiri K, Alves S, Tesson C, den Dunnen W, Seeler JS, Brice A, Sittler A.
    Dis Model Mech; 2019 Jan 11; 12(1):. PubMed ID: 30559154
    [Abstract] [Full Text] [Related]

  • 8. Reelin is a target of polyglutamine expanded ataxin-7 in human spinocerebellar ataxia type 7 (SCA7) astrocytes.
    McCullough SD, Xu X, Dent SY, Bekiranov S, Roeder RG, Grant PA.
    Proc Natl Acad Sci U S A; 2012 Dec 26; 109(52):21319-24. PubMed ID: 23236151
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous bergmann glia degeneration.
    Furrer SA, Mohanachandran MS, Waldherr SM, Chang C, Damian VA, Sopher BL, Garden GA, La Spada AR.
    J Neurosci; 2011 Nov 09; 31(45):16269-78. PubMed ID: 22072678
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Spinocerebellar ataxia Type 7: clinical and genetic study of a new Moroccan family (case report).
    Bouzid FZ, Mansouri M, Abdelaziz C, Louhab N, Bernard S, Strubi-Vuillaume I, Dafir K, Aboussair N.
    Pan Afr Med J; 2021 Nov 09; 38():162. PubMed ID: 33995769
    [Abstract] [Full Text] [Related]

  • 13. SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7.
    Janer A, Werner A, Takahashi-Fujigasaki J, Daret A, Fujigasaki H, Takada K, Duyckaerts C, Brice A, Dejean A, Sittler A.
    Hum Mol Genet; 2010 Jan 01; 19(1):181-95. PubMed ID: 19843541
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy.
    Michalik A, Martin JJ, Van Broeckhoven C.
    Eur J Hum Genet; 2004 Jan 01; 12(1):2-15. PubMed ID: 14571264
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Longitudinal MRI and 1H-MRS study of SCA7 mouse forebrain reveals progressive multiregional atrophy and early brain metabolite changes indicating early neuronal and glial dysfunction.
    Pérot JB, Niewiadomska-Cimicka A, Brouillet E, Trottier Y, Flament J.
    PLoS One; 2024 Jan 01; 19(1):e0296790. PubMed ID: 38227598
    [Abstract] [Full Text] [Related]

  • 18. Requirement for zebrafish ataxin-7 in differentiation of photoreceptors and cerebellar neurons.
    Yanicostas C, Barbieri E, Hibi M, Brice A, Stevanin G, Soussi-Yanicostas N.
    PLoS One; 2012 Jan 01; 7(11):e50705. PubMed ID: 23226359
    [Abstract] [Full Text] [Related]

  • 19. Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.
    Garden GA, La Spada AR.
    Cerebellum; 2008 Jan 01; 7(2):138-49. PubMed ID: 18418675
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.